Managing an effective treatment for neuroleptic malignant syndrome

  title={Managing an effective treatment for neuroleptic malignant syndrome},
  author={Udo Reulbach and Carmen D{\"u}tsch and Teresa Biermann and Wolfgang Sperling and Norbert Joachim Thuerauf and Johannes Kornhuber and Stefan Bleich},
  journal={Critical Care},
  pages={R4 - R4}
INTRODUCTION Neuroleptic malignant syndrome (NMS) is a rare, but sometimes fatal, adverse reaction to neuroleptics characterized principally by fever and rigor. The aim of this study was to prove the efficacy of different NMS treatment strategies, focusing on the efficacy of dantrolene. METHODS Altogether, 271 case reports were included. These cases were categorized into four treatment groups and compared to each other according to effectiveness of therapy within 24 hours, mortality, complete… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 35 extracted citations

Electroconvulsive therapy as treatment for malignant neuroleptic syndrome

Ernesto José Verdura Vizcaínoa, Daniel Ballesteros Sanza, Javier Sanz-Fuentenebrob


Publications referenced by this paper.
Showing 1-10 of 26 references

Neuroleptic malignant syndrome in cancer treatment.

Palliative & supportive care • 2005
View 1 Excerpt

Recognizing neuroleptic malignant syndrome.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne • 2004
View 3 Excerpts

Treating neuroleptic malignant syndrome as catatonia.

Journal of clinical psychopharmacology • 2001
View 1 Excerpt

The role of calcium and peripheral catecholamines in the pathophysiology of neuroleptic malignant syndrome

RJ Guerra
Psychiatric Annals • 2000
View 1 Excerpt

Similar Papers

Loading similar papers…